← Leaderboards
James Leyden
University Of Pennsylvania
$248,292
Attributed
$248,292
Total exposure
1
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding mix
By agency
NIH$248,292 · 1
By mechanism
M01$248,292 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of Pennsylvania
Same institution · by research overlap
- Sean P Hennessy$26,496,214
- Rob R Macgregor$4,980,820
- Jane B Alavi$1,520,103
- Daniel Sterman$5,215,085
- Vladimir R Muzykantov$31,969,177
Others in their field
Top investigators on “13 Cis Retinoate”
- Charles A Coltman · Southwest Oncology Group$18,209,974
- Diane M. Thiboutot · Pennsylvania State Univ Hershey Med Ctr$2,823,189
- Joan M O'Brien · University Of California San Francisco$2,500,518
- Charles Patrick Reynolds · Texas Tech University Health Scis Center$2,449,450
- Swapan K Ray · Medical University Of South Carolina$2,341,331
- Robert C Seeger · University Of Southern California$2,316,439
Research focus
13 Cis RetinoateAcneClinical ResearchClinical Trial Phase IDrug InteractionsEthinyl EstradiolFemaleHuman SubjectHuman Therapy EvaluationNorethindroneOral ContraceptivesPharmacokinetics
Grant awards (6)
ACCUTANE NF AND ORAL CONTRACEPTIVE TABLETS IN PREMENOPAUSAL WOMEN W NODULAR ACNE$124,146
M01 · FY2002 · RR
ACCUTANE NF AND ORAL CONTRACEPTIVE TABLETS IN PREMENOPAUSAL WOMEN W NODULAR ACNE$124,146
M01 · FY2001 · RR
ACCUTANE NF AND ORAL CONTRACEPTIVE TABLETS IN PREMENOPAUSAL WOMEN W NODULAR ACNE$0
M01 · FY2001 · RR
ACCUTANE NF AND ORAL CONTRACEPTIVE TABLETS IN PREMENOPAUSAL WOMEN W NODULAR ACNE$0
M01 · FY2000 · RR
ACCUTANE NF AND ORAL CONTRACEPTIVE TABLETS IN PREMENOPAUSAL WOMEN W NODULAR ACNE$0
M01 · FY2000 · RR
ACCUTANE NF AND ORAL CONTRACEPTIVE TABLETS IN PREMENOPAUSAL WOMEN W NODULAR ACNE$0
M01 · FY2000 · RR